The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
After raking in record amounts of venture capital funding in 2017 and 2018, Indiana life science companies saw funding drop last year by double-digits, while the average deal amount dipped sharply as well.
A bill that tries to address surprise out-of-network fees was among several health care-related measures proposed Monday by Indiana lawmakers during the first day of the General Assembly.
The year didn’t feature any hostile takeovers or huge disasters. But a lot of companies made big strides in 2019, including Eli Lilly and Co., Corteva and Elanco. And many rejoiced when Washington ended a 2.3% tax on thousands of medical devices.
The repeal ends a 2.3% tax on thousands of medical devices, from stents and catheters to pacemakers and MRI machines. Indiana is home to 155 device-makers, ranging from small metal shops to multibillion-dollar manufacturers.
CEO Gail Boudreaux’s recent comments at a health care summit dampened speculation that Anthem might create its own physician group, something the insurer tried unsuccessfully two decades ago.
Neuropsychiatric Hospitals LLC said it is developing a 64-bed hospital in Greenwood that will serve patients with complex medical and psychiatric condition.
Medistar Corp. of Texas has filed an application to build a 42,610-square-foot building at 795 North Emerson Avenue, a vacant and undeveloped site about a mile south of Franciscan Health Indianapolis.
The expansion is the latest move by a large Indianapolis health system to expand cancer care, a fast-growing and competitive medical field.
Indianapolis-based Cornerstone Cos. has invested more than $84 million in recent years to buy medical office buildings, clinics and surgery centers. Now it is about to start its fifth investment fund.